Skip to main content
logo
VitaSpring Biomedical Co. Ltd. (VSBC)
OTCMKTS · Delayed Price · Currency is USD
0.0318
0.00 (0.00%)
At close: Oct 8, 2026

VitaSpring Biomedical Ratios and Metrics

Millions USD. Fiscal year is Feb - Jan.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Market Capitalization
752313,1053,0832,891
Market Cap Growth
-78.80%66.73%-99.00%0.72%6.64%296.72%
Enterprise Value
952313,1063,0842,892
Last Close Price
0.030.250.1515.0014.9314.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
PE Ratio
-----3178.77
PS Ratio
-----515.09
PB Ratio
-1.41-11.69-7.73-926.95-1286.611832.78
P/TBV Ratio
-----1832.78

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
EV/Sales Ratio
-----515.14
EV/EBITDA Ratio
-----2547.59
EV/EBIT Ratio
-----2566.49

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Debt / Equity Ratio
-0.52---0.03-0.110.29
Debt / EBITDA Ratio
-----0.38
Net Debt / Equity Ratio
-0.5100-0.02-0.100.23
Net Debt / EBITDA Ratio
-5.390.010-0.06-0.060.31
Net Debt / FCF Ratio
226.880.780.02-2.00-3.01-1.04
Asset Turnover
-----2.96
Quick Ratio
0.01000.010.131.76
Current Ratio
0.010.0000.010.141.76
Return on Equity (ROE)
-----108.68%
Return on Assets (ROA)
-1783.42%-1655.78%-560.17%-153.34%-119.50%37.13%
Return on Invested Capital (ROIC)
-----91.65%
Return on Capital Employed (ROCE)
20.20%8.70%16.90%33.10%181.40%60.40%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jan '26 Jan '25 Jan '24 Jan '23 Jan '22
Earnings Yield
-6.92%-0.80%-2.50%-0.04%-0.14%0.03%
FCF Yield
0.16%-0.01%-0.05%-0.00%-0.00%-0.01%
Buyback Yield / Dilution
----0.25%-0.26%-126.13%